Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
97.30    2.80 (2.96%)
Bid:
97.00
Ask:
97.30
Spread: 0.30 (0.309%)
Market Cap: £358.39m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

FY2025 First-Half Trading Update

9 Sep 2024 07:00

RNS Number : 3304D
C&C Group Plc
09 September 2024
 

FY2025 First-Half Trading Update

 

Earnings in line with expectations; underlying Operating Profit of €39m-€41m, Core Revenues in line

 

Dublin, London, 9 September 2024: C&C Group plc ('C&C' or the 'Group') announces that earnings in the first half of the financial year to 31 August 2024 have been in line with expectations, with Net Revenues expected to be -3%1, reflecting growth in Matthew Clark & Bibendum, in-line performance across our core and premium brands, offset by the impact from the disposal of our NAB business in Ireland, lower contract brewing volumes and softer cider volumes in GB. Underlying Operating Profit is expected in the range of €39m-€41m, in line with our expectations, principally reflecting the phased rebuilding of our Distribution business profitability following last year's ERP disruption.

 

Tennent's achieved volume and value share growth over the latest 12-weeks2, supported by targeted marketing campaigns around the Euro 2024 tournament and, despite mixed summer weather, Bulmers outperformed the cider market in Ireland3. Our Premium beer and cider brands, driven by Menabrea and Orchard Pig, continued to perform strongly, reporting double digit revenue growth.

 

Performance in our Matthew Clark and Bibendum business has also been encouraging with Net Revenues expected to be +2%. Recovery from lost distribution customers in FY2024 has been strong, with distribution points for Matthew Clark and Bibendum in August +10% compared to August 2023. This growth, together with the efficiency initiatives implemented in the year to date, is expected to result in improved distribution margins in H1 FY2025.

 

Distribution Agreement with Budweiser Brewing Group

 

C&C and Budweiser Brewing Group ('BBG'), part of AB InBev, have mutually agreed to restructure elements of our trading relationship. Effective from 1st January 2025, C&C will reassume control and distribution of the Group's cider portfolio, including Magners, in Great Britain. On the same date, AB InBev will assume control and distribution of its beer portfolio in the Off Trade in the Republic of Ireland. Bringing the sales, trade marketing and distribution responsibilities in house will provide both companies with the opportunity to strengthen their respective brand portfolios and distribution platforms.

 

Outlook and Capital Returns

 

While current market conditions remain challenging, improving efficiencies, business simplification, winning customers and brand distribution remain our top priorities. We remain confident on achieving our operating profit target for the current financial year and making progress towards the operating profit target of €100m by FY2027.

 

The Board reaffirms its intention to distribute at least €150million to shareholders over three years while maintaining the Group's financial leverage target of approximately 1x EBITDA on a pre-IFRS16 basis. The second €15m tranche of our share buyback programme will commence today, 9 September 2024.

 

Board and CEO Appointment Process

 

Since the Annual General Meeting on 15 August 2024, we have been pleased to welcome Feargal O'Rourke as Non-Executive Director of the Board. Prior to retirement Feargal was Managing Partner of PwC Ireland and brings his considerable financial expertise to C&C. As previously announced, we intend to make a further non-executive appointment to the Board in the near future. We have also commenced the recruitment process for the new Chief Executive Officer with the support of executive search firm Russell Reynolds Associates. A progress update on these appointments will be provided in due course.

 

1 On a constant currency basis

2 On-Trade - CGA OPM (BWS) 52 w/e 13/7/2024, Off-Trade - IRI (Circana) Total GB 52 w/e 13/7/2024.

CGA 13 w/e to 30.06.24 - Ireland Total Cider

 

 

ENDS

Contacts

 

C&C Group plc

Email: investor.relations@candcgroup.ie

 

Investors, Analysts & Media

 

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 6025988 / +353 87 707 8379

Email: CandCGroup@fticonsulting.com

 

 

About C&C Group plc

 

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

 

· C&C Group's portfolio of owned/exclusive brands include Bulmers, the leading Irish cider brand and Tennent's, the leading Scottish beer brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

· C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

· C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group plc is an Irish incorporated FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBVLLBZKLBBBD
Date   Source Headline
5th Jun 20177:00 amRNSTransaction in Own Shares
2nd Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20174:20 pmRNSDirector/PDMR Shareholding
1st Jun 20171:28 pmRNS2017 Final Dividend - Scrip Alternative
1st Jun 20179:25 amRNSTotal Voting Rights
1st Jun 20177:05 amBUSDirector Declaration
1st Jun 20177:00 amRNSBlock Listing Six Monthly Return
1st Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20177:00 amBUSDirectorate change
26th May 20176:05 pmRNSTransaction in Own Shares
26th May 20177:00 amRNSTransaction in Own Shares
25th May 20174:00 pmRNSDirector/PDMR Shareholding
23rd May 20178:59 amRNSHolding(s) in Company
19th May 20177:05 amBUSDirector Declaration
19th May 20177:00 amBUSStatement re Appointment of Non-executive Director
17th May 20177:00 amBUSFinal Results
16th May 20178:29 amRNSHolding(s) in Company
9th May 20179:23 amRNSHolding(s) in Company
8th May 20177:00 amBUSNotice of Results
2nd May 20172:10 pmRNSTotal Voting Rights
13th Apr 20175:31 pmRNSDirector/PDMR Shareholding
7th Apr 20178:52 amRNSHolding(s) in Company
3rd Apr 20175:51 pmRNSHolding(s) in Company
3rd Apr 201710:11 amRNSTransaction in Own Shares - Replacement
3rd Apr 201710:02 amRNSTotal Voting Rights
3rd Apr 20177:00 amBUSTransaction in Own Shares
31st Mar 20178:46 amRNSDirector Declaration
31st Mar 20177:00 amBUSDirectorate change
20th Mar 20179:06 amRNSHolding(s) in Company
10th Mar 20177:00 amBUSStatement re Pre-Close Trading Update
8th Mar 20174:52 pmRNSHolding(s) in Company
7th Mar 20173:00 pmBUSStatement re Notice of Pre-Close Trading Update
7th Mar 20177:00 amRNSHolding(s) in Company
1st Mar 201710:11 amRNSTotal Voting Rights
28th Feb 20174:07 pmRNSHolding(s) in Company
24th Feb 20178:59 amRNSHolding(s) in Company
16th Feb 20176:02 pmRNSDirector/PDMR Shareholding
8th Feb 201712:32 pmRNSHolding(s) in Company
8th Feb 201712:29 pmRNSHolding(s) in Company
7th Feb 20174:18 pmRNSHolding(s) in Company
1st Feb 20175:00 pmRNSHolding(s) in Company
1st Feb 201712:16 pmRNSTotal Voting Rights
3rd Jan 201710:13 amRNSTotal Voting Rights
22nd Dec 20164:30 pmRNSDirector/PDMR Shareholding
21st Dec 20162:47 pmRNSDirector/PDMR Shareholding
21st Dec 20169:00 amBUSStatement re Death of Non-Executive Director
16th Dec 20167:00 amRNSMain Securities Market Notice
14th Dec 20167:00 amRNSScrip Alternative - Additional Listing
12th Dec 20167:00 amBUSAgreement
1st Dec 201611:22 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.